Table 2.
Baseline characteristics | Mosapride citrate SR group (n = 57) | Mosapride citrate CR group (n = 57) | P-value |
---|---|---|---|
Age (yr) | |||
Mean ± SD | 44.37 ± 14.58 | 43.12 ± 14.64 | 0.753a |
Median | 42.00 | 39.00 | |
Min, Max | 22.00, 68.00 | 23.00, 68.00 | |
Age groups (yr) | |||
< 65 | 53 (93.0%) | 54 (94.7%) | > 0.999b |
≥ 65 | 4 (7.0%) | 3 (5.3%) | |
Sex | |||
Male | 9 | 7 | 0.589c |
Female | 48 | 50 | |
Height (cm) | |||
Mean ± SD | 161.96 ± 9.04 | 161.27 ± 6.44 | 0.744a |
Median | 161.50 | 161.70 | |
Min, Max | 148.00, 184.00 | 141.00, 173.00 | |
Weight (kg) | |||
Mean ± SD | 60.53 ± 10.96 | 57.84 ± 9.14 | 0.210a |
Median | 58.20 | 57.00 | |
Min, Max | 42.00, 92.80 | 42.40, 92.70 | |
BMI (kg/m2) | |||
Mean ± SD | 22.96 ± 2.69 | 22.21 ± 3.04 | 0.088a |
Median | 23.27 | 21.53 | |
Min, Max | 18.18, 28.59 | 17.37, 34.89 |
BMI, body mass index.
aWilcoxon rank sum test.
bFisher’s exact test.
cPearson’s chi-square test .